Fortrea Holdings Inc.: Insider Buying After Revenue Forecast Increase Totals $407,150
Reading Time: 2 minutes
Fortrea Holdings Inc. (FTRE) is a global Contract Research Organization (CRO) specializing in supporting the biopharmaceutical industry. Essentially, Fortrea is a service company that assists pharmaceutical and biotechnology companies in planning and conducting clinical trials and developing new drugs. The focus is on reducing the complexity and costs of drug development, allowing clients to bring their products to market faster and more efficiently. The company released its report for the second quarter on August 6. Accordingly, revenue increased...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
